CASE Blog: PBMs – The Bullies of the Healthcare System
March 6, 2019 We continue to support President Trump’s efforts and enthusiasm to bring down healthcare prices. Our suggestion: let’s...
March 6, 2019 We continue to support President Trump’s efforts and enthusiasm to bring down healthcare prices. Our suggestion: let’s...
President Trump is expected to touch upon areas of agreement between both parties and all Americans. in tonight’s State of...
Gerard Scimeca – Chairman, CASE February 5, 2019 – https://bit.ly/2HTCLae Health care was the top issue when voters went to the polls in...
Gerard Scimeca – Chairman, CASE February 1, 2019 – https://bit.ly/2S1zs5j It’s no secret how many Democrats in Washington openly condemn...
January 30, 2019 https://bit.ly/2Sb45ol Gerard Scimeca – Chairman CASE From an economic growth perspective, 2018 was an exceptional year....
This week, the Senate has a unique opportunity to stand up for consumers by confirming Kathy Kraninger to serve as...
Gerard Scimeca – Chairman, CASE December 3, 2018 – https://bit.ly/2BMSzGE The G20 Summit is just getting underway, sure to be as...
Gerard Scimeca – Chairman, CASE October 23, 2018 – https://bit.ly/2NZ3Sy4 In his proposal to lift restrictions on year-round sales of gasoline...
Gerard Scimeca – Chairman, CASE August 31, 2018 – https://bit.ly/2xYsfXy Seinfeld’s George Costanza never studied to be an architect, but that didn’t stop...
May 22, 2018 Last week, pharmaceutical manufacturer Amgen announced that a new drug treating migraines will cost less than analysts...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers